Marc Schrader

Outlook Microsoft Office 365 Mobile Friendly Google Analytics Google Font API Google Tag Manager Nginx

healthcare biotechnology life sciences pharmaceutical manufacturing specialty pharmaceuticals innovative medicines rare diseases neuromuscular diseases duchenne muscular dystrophy dmd treatments vamorolone agamree fda approved medications eu approval orphan drug high unmet medical need pediatric medicine clinical trials research & development patient care patient stories healthcare professionals scientific publications investor relations corporate governance business development partnership management drug commercialization health authorities adverse reaction reporting pharmaceutical investments analyst coverage financial reports clinical research physician resources pharmacist resources publications medical compliance regulatory affairs international business partner management investor toolbox corporate presentations innovative therapies life-altering conditions patient quality of life pharma company pharmaceutical pipeline product development commercial strategy healthcare innovation career opportunities dynamic workforce neuromuscular disorders mitochondrial disorders dissociative steroid high unmet medical needs cystic fibrosis patient access programs commercial partnerships healthcare providers regulatory approvals pharmaceutical industry genetic disorders therapeutic options patient demographics european markets north america global expansion clinical studies commitment to patients collaboration accountability treatment options health care health wellness & fitness hospital & health care pharmaceuticals medical b2b